Publication of Cancellation of Entries for Kinds of Medical Devices from the Australian Register of Therapeutic Goods – Neosurgical Pty Ltd - 169294

Overview

The Therapeutic Goods Act 1989, enacted by the Commonwealth Parliament, serves to regulate therapeutic goods in Australia, including medical devices. This legislation was introduced to ensure that therapeutic goods available in Australia are safe, of acceptable quality, and their benefits outweigh their risks. The Act establishes a framework for the regulation of therapeutic goods, including the Australian Register of Therapeutic Goods (ARTG). The Therapeutic Goods Administration (TGA), operating under the auspices of the Department of Health, is responsible for administering the Act. This particular notification, published under section 41GP of the Act, concerns the cancellation of an entry for a specific kind of medical device from the ARTG. The cancellation of the ARTG entry for an internal ligament prosthesis, sponsored by Neosurgical Pty Ltd, was due to the delegate of the Secretary being satisfied that the certifications related to the device's inclusion in the ARTG were incorrect or no longer correct in a material particular. The objective of this notification is to inform the public of changes to the ARTG and to maintain the integrity and safety of therapeutic goods available in Australia.

Scope and Application

The Therapeutic Goods Act 1989 applies to any person or entity involved in the supply, importation, advertising, or sponsorship of therapeutic goods in Australia. This includes individuals, businesses, and manufacturers of medical devices, and extends to the conduct and transactions associated with these activities. The Act operates nationally, covering the entire Commonwealth of Australia, and its provisions are enforced by the Department of Health and Ageing. The Act provides for the regulation of therapeutic goods, including medical devices, through the Australian Register of Therapeutic Goods (ARTG). The Act does not apply to certain goods that are exempt under specified circumstances, such as personal use or research purposes. The application and scope of the Act can be extended or restricted through subordinate instruments, which provide additional detail and guidance on its implementation. In this instance, the Act is applied to the cancellation of an entry for a kind of medical device from the ARTG, specifically an internal ligament prosthesis, due to incorrect or outdated certifications, impacting the sponsor Neosurgical Pty Ltd.

Key Provisions

The main operative sections of this legislation, specifically section 41GP of the Therapeutic Goods Act 1989 (the Act), require the publication of particulars regarding the cancellation of an entry for a kind of medical device from the Australian Register of Therapeutic Goods (ARTG). In this case, the cancellation pertains to the entry for an internal ligament prosthesis with an ARTG number of 169294, sponsored by Neosurgical Pty Ltd (section 41GP(1)). The reason for the cancellation is detailed under section 41GN(1)(f) of the Act, which indicates that the delegate of the Secretary is satisfied that the certifications associated with the application for inclusion of the device in the ARTG are incorrect or no longer correct in a material particular. The Act imposes specific obligations and requirements on parties and entities involved in the registration and maintenance of medical devices within the ARTG. For instance, section 41FD requires that all applications for inclusion in the ARTG must be accompanied by certifications that the device meets the necessary standards and criteria. Furthermore, section 41FN(3)(a)(i) stipulates that sponsors of medical devices must ensure that any information provided in support of the application remains accurate and up-to-date. If these certifications are found to be incorrect or outdated, the delegate of the Secretary, in this case Dr Jane Cook, has the authority to cancel the entry from the ARTG. In terms of offences, penalties, or consequences for breach, the Therapeutic Goods Act 1989 provides a framework for both civil and criminal penalties. While specific penalties are not detailed within this notification of cancellation, breaches of the Act can lead to significant repercussions. For example, under section 42DA of the Act, a person who makes a false or misleading representation in relation to a therapeutic good can be subject to civil penalties, including fines. Additionally, under section 42DB, criminal penalties can apply, which may include fines and imprisonment, depending on the severity and intent of the breach. The maximum penalties are not explicitly stated in this notification but can be found within the broader provisions of the Act.